Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae

Epidemiology and Infection

Volumn 139, Issue 9, 2011, Pages 1307-1316

  Lin, S H ^a,b   Lai, C C ^c   Tan, C K ^c   Liao, W H ^a   Hsueh, P R ^d  

^a Taipei County Hospital   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Bacteraemic; community acquired pneumonia; non bacteraemic; outcome; Streptococcus pneumoniae

Indexed keywords

CEFOTAXIME; CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN G; TETRACYCLINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC SENSITIVITY; ANTIGEN DETECTION; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CHILD; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; BACTEREMIA; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STREPTOCOCCUS PNEUMONIAE; TAIWAN; TREATMENT OUTCOME;

EID: 80053126248     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268810002402     Document Type: Article

References (34)

1. Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clinical Infectious Diseases 1992; 14: 801-807
2. Tilghman RC, Finland M. Clinical significance of bacteremia in pneumococcal pneumonia. Archives of Internal Medicine 1937; 59: 602-619
3. Lagos R, et al. Age- and serotype-specific pediatric invasive pneumococcal disease : insights from systematic surveillance in Santiago, Chile, 1994-2007 Journal of Infectious Diseases 2008; 198: 1809-1817
4. Lujan M, et al. Prospective observational study of bacteremic pneumococcal pneumonia: effect of discordant therapy on mortality. Critical Care Medicine 2004; 32: 625-631 (Pubitemid 38340054)
5. Martinez JA, et al. Addition of a macrolide to a betalactam- based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clinical Infectious Diseases 2003; 36: 389-395 (Pubitemid 36241302)
6. Baddour LM, et al. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. American Journal of Respiratory and Critical Care Medicine 2004; 170: 440-444 (Pubitemid 39214620)
7. Dominguez A, et al. Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: a case-control study. Clinical Infectious Diseases 2005; 40: 1250-1257 (Pubitemid 40570233)
8. Tsigrelis C, et al. Decreases in case-fatality and mortality rates for invasive pneumococcal disease in Olmsted County, Minnesota, during 1995-2007: a population-based study. Clinical Infectious Diseases 2008; 47: 1367-1371
9. Dominguez J, et al. Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples. Chest 2001; 119: 243-249 (Pubitemid 32150574)
10. Smith MD, et al. Diagnosis of Streptococcus pneumonia infections in adults with bacteremia and community-acquired pneumonia: clinical comparison of pneumococcal PCR and urinary antigen detection. Journal of Clinical Microbiology 2009; 47: 1046-1049
11. Vila-Corcoles A, et al. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study. Clinical Infectious Diseases 2006; 43: 860-868 (Pubitemid 44435513)
12. Diaz A, et al. Etiology of community-acquired pneumonia in hospitalized patients in Chile: the increasing prevalence of respiratory viruses among classic pathogens. Chest 2007; 131: 779-787 (Pubitemid 46446870)
13. Vila-Corcoles A, et al. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched casecontrol study. Vaccine 2009; 27: 1504-1510
14. Charles PG, et al. The etiology of community-acquired pneumonia in Australia : why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clinical Infectious Diseases 2008; 46: 1513-1521 (Pubitemid 351706731)
15. BinaxNOW. Product Instruction Manual. Portland, ME: Binax Inc., 1998
16. Ruoff KL. Streptococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology, 6th edn. Washington, DC: American Society for Microbiology, 1995, pp. 299-307
17. National Committee for Clinical Laboratory Standards. Performance standard for antimicrobial disk susceptibility tests. Approved standard, 5th edn. NCCLS document M2-A5 National Committee for Clinical Laboratory Standards, Wayne, PA, 1993
18. Clinical and Laboratory Standards Institute. Erformance standards for antimicrobial susceptibility testing ; eighteenth informational supplement. CLSI document M100-S18 Wayne, PA, 2008
19. Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Annals of Internal Medicine 1964; 60: 759-776
20. Musher DM, et al. Bacteremic and non-bacteremic pneumococcal pneumonia. A prospective study. Medicine (Baltimore) 2000; 79: 210-221
21. Brandenburg JA, et al. Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia. Journal of General Internal Medicine 2000; 15: 638-646
22. Watari M, et al. Community-acquired pneumococcal pneumonia: a comparative study of bacteremic and non-bacteremic patients. Nihon Kokyuki Gakkai Zasshi 2000; 38: 253-258 [abstract in English].
23. Jover F, et al. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia. European Journal of Internal Medicine 2008; 19: 15-21
24. Ramirez JA, Bordon J. Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumonia pneumonia. Archives of Internal Medicine 2001; 161: 848-850 (Pubitemid 32225393)
25. Marrie TJ, Low DE, De Carolis E. A comparison of bacteremic pneumococcal pneumonia with nonbacteremic community-acquired pneumonia of any etiology - results from a Canadian multicentre study. Canadian Respiratory Journal 2003; 10: 368-374 (Pubitemid 37441565)
26. Bordon J, et al. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. Chest 2008; 133: 618-624 (Pubitemid 351367368)
27. Roson B, et al. Causes and factors associated with early failure in hospitalized patients with communityacquired pneumonia. Archives of Internal Medicine 2004; 164: 502-528
28. Arancibia F, et al. Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa : incidence, risk, and prognosis. Archives of Internal Medicine 2002; 162: 1849-1858
29. Kallen AJ, et al. Staphylococcus aureus communityacquired pneumonia during the 2006 to 2007 influenza season. Annals of Emergency Medicine 2009; 53: 358-365
30. Tleyjeh IM, et al. The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and metaanalysis. Clinical Infectious Diseases 2006; 42: 788-797 (Pubitemid 43363934)
31. Gutiérrez F, et al. Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. Clinical Infectious Diseases 2003; 36: 286-292 (Pubitemid 36169663)
32. García-Suá rez MM, et al. Diagnostic detection of Streptococcus pneumoniae PpmA in urine. Clinical Microbiology and Infection 2009; 15: 443-453
33. Liao WH, et al. Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan. European Journal of Clinical Microbiology & Infectious Diseases 2010; 29: 489-492
34. Lin SH, et al. Declining incidence of non-bacteremic pneumococcal pneumonia in hospitalized elderly patients at a tertiary care hospital after the introduction of pneumococcal vaccines in Taiwan, 2004 to 2008 Journal of the American Geriatrics Society 2010; 58: 195-196